{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T21:49:56Z","timestamp":1768081796405,"version":"3.49.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018568","name":"Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province","doi-asserted-by":"publisher","award":["pdjh2023b0107"],"award-info":[{"award-number":["pdjh2023b0107"]}],"id":[{"id":"10.13039\/501100018568","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013254","name":"National College Students Innovation and Entrepreneurship Training Program","doi-asserted-by":"publisher","award":["202212121008"],"award-info":[{"award-number":["202212121008"]}],"id":[{"id":"10.13039\/501100013254","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Many studies have shown an association between COVID-19 and autoimmune diseases (ADs). Studies on COVID-19 and ADs have also increased significantly, but there is no bibliometric analysis to summarize the association between COVID-19 and ADs. The purpose of this study was to perform a bibliometric and visual analysis of published studies related to COVID-19 and ADs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Based on the Web of Science Core Collection SCI-Expanded database, we utilize Excel 2019 and visualization analysis tools Co-Occurrence13.2 (COOC13.2), VOSviewer, CiteSpace, and HistCite for analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 1736 related kinds of papers were included, and the number of papers presented an overall increasing trend. The country\/region with the most publications is the USA, the institution is the Harvard Medical School, the author is Yehuda Shoenfeld from Israel, and the journal is <jats:italic>Frontiers in Immunology<\/jats:italic>. Research hotspots include immune responses (such as cytokines storm), multisystem ADs (such as systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis), treatment modalities (such as hydroxychloroquine, rituximab), vaccination and autoimmune mechanisms (such as autoantibodies, molecular mimicry). The future research direction may be the mechanisms and treatment ideas of the association between ADs and COVID-19 (such as NF-\u03baB, hyperinflammation, antiphospholipid antibodies, neutrophil extracellular traps, granulocyte-macrophage colony-stimulating factor), other cross-diseases of COVID-19 and ADs (such as inflammatory bowel disease, chronic mucocutaneous candidiasis, acute respiratory distress syndrome).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The growth rate of publications regarding ADs and COVID-19 has risen sharply. Our research results can help researchers grasp the current status of ADs and COVID-19 research and find new research directions in the future.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10238-023-01089-y","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T12:02:50Z","timestamp":1688385770000},"page":"3549-3564","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Knowledge mapping of COVID-19 and autoimmune diseases: a visual and bibliometric analysis"],"prefix":"10.1007","volume":"23","author":[{"given":"Youao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixuan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"issue":"6","key":"1089_CR1","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1172\/JCI78086","volume":"125","author":"A Marson","year":"2015","unstructured":"Marson A, Housley WJ, Hafler DA. Genetic basis of autoimmunity. J Clin Invest. 2015;125(6):2234\u201341.","journal-title":"J Clin Invest"},{"issue":"2","key":"1089_CR2","doi-asserted-by":"crossref","first-page":"102743","DOI":"10.1016\/j.autrev.2020.102743","volume":"20","author":"ZX Xiao","year":"2021","unstructured":"Xiao ZX, Miller JS, Zheng SG. An updated advance of autoantibodies in autoimmune diseases. Autoimmun Rev. 2021;20(2):102743.","journal-title":"Autoimmun Rev"},{"key":"1089_CR3","doi-asserted-by":"crossref","first-page":"939433","DOI":"10.3389\/fimmu.2022.939433","volume":"13","author":"F Wu","year":"2022","unstructured":"Wu F, Gao J, Kang J, Wang X, Niu Q, Liu J, et al. Knowledge mapping of exosomes in autoimmune diseases: a bibliometric analysis (2002\u20132021). Front Immunol. 2022;13:939433.","journal-title":"Front Immunol"},{"issue":"7","key":"1089_CR4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.autrev.2019.05.001","volume":"18","author":"H Khan","year":"2019","unstructured":"Khan H, Sureda A, Belwal T, et al. Polyphenols in the treatment of autoimmune diseases. Autoimmun Rev. 2019;18(7):647\u201357.","journal-title":"Autoimmun Rev"},{"issue":"11","key":"1089_CR5","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1373\/clinchem.2012.189480","volume":"58","author":"D Konforte","year":"2012","unstructured":"Konforte D, Diamandis EP, van Venrooij WJ, Lories R, Ward MM. Autoimmune diseases: early diagnosis and new treatment strategies. Clin Chem. 2012;58(11):1510\u20134.","journal-title":"Clin Chem"},{"issue":"6","key":"1089_CR6","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cmet.2021.05.005","volume":"33","author":"N Hanssen","year":"2021","unstructured":"Hanssen N, de Vos WM, Nieuwdorp M. Fecal microbiota transplantation in human metabolic diseases: From a murky past to a bright future? Cell Metab. 2021;33(6):1098\u2013110.","journal-title":"Cell Metab"},{"key":"1089_CR7","doi-asserted-by":"crossref","first-page":"689044","DOI":"10.3389\/fimmu.2021.689044","volume":"12","author":"P Shen","year":"2021","unstructured":"Shen P, Lin W, Deng X, et al. Potential implications of quercetin in autoimmune diseases. FRONT IMMUNOL. 2021;12:689044.","journal-title":"FRONT IMMUNOL"},{"key":"1089_CR8","first-page":"e66452","volume":"376","author":"J Hahn","year":"2022","unstructured":"Hahn J, Cook NR, Alexander EK, et al. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ-Brit Med J. 2022;376:e66452.","journal-title":"BMJ-Brit Med J"},{"issue":"4","key":"1089_CR9","doi-asserted-by":"crossref","first-page":"102792","DOI":"10.1016\/j.autrev.2021.102792","volume":"20","author":"A Dotan","year":"2021","unstructured":"Dotan A, Muller S, Kanduc D, David P, Halpert G, Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev. 2021;20(4):102792.","journal-title":"Autoimmun Rev"},{"issue":"12","key":"1089_CR10","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.3390\/cells10123592","volume":"10","author":"AE Gracia-Ramos","year":"2021","unstructured":"Gracia-Ramos AE, Martin-Nares E, Hern\u00e1ndez-Molina G. New onset of autoimmune diseases following COVID-19 diagnosis. Cells-Basel. 2021;10(12):3592.","journal-title":"Cells-Basel"},{"key":"1089_CR11","doi-asserted-by":"crossref","first-page":"645013","DOI":"10.3389\/fimmu.2021.645013","volume":"12","author":"KT Tang","year":"2021","unstructured":"Tang KT, Hsu BC, Chen DY. Autoimmune and rheumatic manifestations associated with COVID-19 in adults: an updated systematic review. Front Immunol. 2021;12:645013.","journal-title":"Front Immunol"},{"issue":"2","key":"1089_CR12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/ACI.0000000000000888","volume":"23","author":"M Votto","year":"2023","unstructured":"Votto M, Castagnoli R, Marseglia GL, Licari A, Brambilla I. COVID-19 and autoimmune diseases: is there a connection? Curr Opin Allergy Clin Immunol. 2023;23(2):185\u201392.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"3","key":"1089_CR13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/annrheumdis-2020-218946","volume":"80","author":"S Akiyama","year":"2021","unstructured":"Akiyama S, Hamdeh S, Micic D, Sakuraba A. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis. Ann Rheum Dis. 2021;80(3):384\u201391.","journal-title":"Ann Rheum Dis"},{"key":"1089_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-023-01028-x","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Peng Y, Xia X. Autoimmune diseases and gut microbiota: a bibliometric and visual analysis from 2004 to 2022. Clin Exp Med. 2023. https:\/\/doi.org\/10.1007\/s10238-023-01028-x.","journal-title":"Clin Exp Med"},{"key":"1089_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-023-01013-4","author":"HY Wu","year":"2023","unstructured":"Wu HY, Liu T, Zhong T, et al. Research trends and hotspots of neoadjuvant therapy in pancreatic cancer: a bibliometric analysis based on the Web of Science Core Collection. Clin Exp Med. 2023. https:\/\/doi.org\/10.1007\/s10238-023-01013-4.","journal-title":"Clin Exp Med"},{"key":"1089_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-022-00971-5","author":"C Wan","year":"2022","unstructured":"Wan C, Kong X, Liao Y, et al. Bibliometric analysis of the 100 most-cited papers about the role of gut microbiota in irritable bowel syndrome from 2000 to 2021. Clin Exp Med. 2022. https:\/\/doi.org\/10.1007\/s10238-022-00971-5.","journal-title":"Clin Exp Med"},{"issue":"2","key":"1089_CR17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","volume":"84","author":"NJ van Eck","year":"2010","unstructured":"van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523\u201338.","journal-title":"Scientometrics"},{"key":"1089_CR18","doi-asserted-by":"crossref","first-page":"737270","DOI":"10.3389\/fpsyt.2021.737270","volume":"12","author":"T Zhou","year":"2021","unstructured":"Zhou T, Qu J, Sun H, Xue M, Shen Y, Liu Y. Research trends and hotspots on montessori intervention in patients with dementia from 2000 to 2021: a bibliometric analysis. Front Psychiatry. 2021;12:737270.","journal-title":"Front Psychiatry"},{"key":"1089_CR19","doi-asserted-by":"crossref","first-page":"1111815","DOI":"10.3389\/fphar.2023.1111815","volume":"14","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Zeng Y, Zheng S, et al. Research hotspots and frotiers of stem cells in stroke: a bibliometric analysis from 2004 to 2022. Front Pharmacol. 2023;14:1111815.","journal-title":"Front Pharmacol"},{"key":"1089_CR20","first-page":"170","volume":"23","author":"L Tan","year":"2023","unstructured":"Tan L, Wang X, Yuan K, et al. Structural and temporal dynamics analysis on drug-eluting stents: history, research hotspots and emerging trends. Bioact Mater. 2023;23:170\u201386.","journal-title":"Bioact Mater"},{"issue":"15","key":"1089_CR21","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/cid\/ciaa237","volume":"71","author":"X Yao","year":"2020","unstructured":"Yao X, Ye F, Zhang M, et al. In Vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020;71(15):732\u20139.","journal-title":"Clin Infect Dis"},{"issue":"6515","key":"1089_CR22","doi-asserted-by":"crossref","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","volume":"370","author":"P Bastard","year":"2020","unstructured":"Bastard P, Rosen LB, Zhang Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370(6515):eabd4585.","journal-title":"Science"},{"issue":"22","key":"1089_CR23","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","volume":"384","author":"A Greinacher","year":"2021","unstructured":"Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. New Engl J Med. 2021;384(22):2092\u2013101.","journal-title":"New Engl J Med"},{"issue":"2","key":"1089_CR24","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s11192-016-2093-0","volume":"109","author":"XW Wang","year":"2016","unstructured":"Wang XW, Fang ZC, Sun XL. Usage patterns of scholarly articles on web of science: a study on web of science usage count. Scientometrics. 2016;109(2):917\u201326.","journal-title":"Scientometrics"},{"issue":"2","key":"1089_CR25","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","volume":"23","author":"S Mehandru","year":"2022","unstructured":"Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022;23(2):194\u2013202.","journal-title":"Nat Immunol"},{"issue":"10","key":"1089_CR26","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/23744235.2021.1924397","volume":"53","author":"SJ Yong","year":"2021","unstructured":"Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis-Nor. 2021;53(10):737\u201354.","journal-title":"Infect Dis-Nor"},{"issue":"7889","key":"1089_CR27","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41586-021-03767-x","volume":"600","author":"COVID-19 Host Genetics Initiative","year":"2021","unstructured":"COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19. Nature. 2021;600(7889):472\u20137.","journal-title":"Nature"},{"issue":"9","key":"1089_CR28","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/annrheumdis-2020-217763","volume":"79","author":"JL Pablos","year":"2020","unstructured":"Pablos JL, Abasolo L, Alvaro-Gracia JM, et al. Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases. Ann Rheum Dis. 2020;79(9):1170\u20133.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1089_CR29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/BOR.0000000000000776","volume":"33","author":"Y Liu","year":"2021","unstructured":"Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. 2021;33(2):155\u201362.","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"1089_CR30","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1136\/annrheumdis-2021-220647","volume":"80","author":"V Furer","year":"2021","unstructured":"Furer V, Eviatar T, Zisman D, et al. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Ann Rheum Dis. 2021;80(10):1330\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1089_CR31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jhep.2021.04.003","volume":"75","author":"F Bril","year":"2021","unstructured":"Bril F, Al DS, Dean M, Fettig DM. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty? J Hepatol. 2021;75(1):222\u20134.","journal-title":"J Hepatol"},{"issue":"7","key":"1089_CR32","doi-asserted-by":"crossref","first-page":"102569","DOI":"10.1016\/j.autrev.2020.102569","volume":"19","author":"J Alijotas-Reig","year":"2020","unstructured":"Alijotas-Reig J, Esteve-Valverde E, Belizna C, et al. Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: a comprehensive review. Autoimmun Rev. 2020;19(7):102569.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"1089_CR33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","volume":"33","author":"T Hirano","year":"2021","unstructured":"Hirano T. IL-6 in inflammation, autoimmunity and cancer. Int Immunol. 2021;33(3):127\u201348.","journal-title":"Int Immunol"},{"key":"1089_CR34","doi-asserted-by":"crossref","first-page":"589474","DOI":"10.3389\/fimmu.2020.589474","volume":"11","author":"AP Spihlman","year":"2020","unstructured":"Spihlman AP, Gadi N, Wu SC, Moulton VR. COVID-19 and systemic lupus erythematosus: focus on immune response and therapeutics. Front Immunol. 2020;11:589474.","journal-title":"Front Immunol"},{"issue":"11","key":"1089_CR35","doi-asserted-by":"crossref","first-page":"e1010253","DOI":"10.1371\/journal.pgen.1010253","volume":"18","author":"Y Wang","year":"2022","unstructured":"Wang Y, Guga S, Wu K, et al. COVID-19 and systemic lupus erythematosus genetics: a balance between autoimmune disease risk and protection against infection. PLoS Genet. 2022;18(11):e1010253.","journal-title":"PLoS Genet"},{"issue":"2","key":"1089_CR36","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/v15020272","volume":"15","author":"A Lupu","year":"2023","unstructured":"Lupu A, Miron IC, Gavrilovici C, et al. Pediatric systemic lupus erythematous in COVID-19 era. Viruses-Basel. 2023;15(2):272.","journal-title":"Viruses-Basel"},{"key":"1089_CR37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.trsl.2020.12.007","volume":"232","author":"R Fernandez-Ruiz","year":"2021","unstructured":"Fernandez-Ruiz R, Paredes JL, Niewold TB. COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease. Transl Res. 2021;232:13\u201336.","journal-title":"Transl Res"},{"issue":"10086","key":"1089_CR38","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","volume":"389","author":"IB McInnes","year":"2017","unstructured":"McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet. 2017;389(10086):2328\u201337.","journal-title":"Lancet"},{"key":"1089_CR39","doi-asserted-by":"crossref","first-page":"860676","DOI":"10.3389\/fimmu.2022.860676","volume":"13","author":"H Hu","year":"2022","unstructured":"Hu H, Tang N, Zhang F, Li L, Li L. Bioinformatics and system biology approach to identify the influences of COVID-19 on rheumatoid arthritis. FRONT IMMUNOL. 2022;13:860676.","journal-title":"FRONT IMMUNOL"},{"issue":"12","key":"1089_CR40","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.3390\/cells10123291","volume":"10","author":"S Dewanjee","year":"2021","unstructured":"Dewanjee S, Kandimalla R, Kalra RS, et al. COVID-19 and rheumatoid arthritis crosstalk: emerging association, therapeutic options and challenges. Cells-Basel. 2021;10(12):3291.","journal-title":"Cells-Basel"},{"issue":"5","key":"1089_CR41","doi-asserted-by":"crossref","first-page":"102523","DOI":"10.1016\/j.autrev.2020.102523","volume":"19","author":"EG Favalli","year":"2020","unstructured":"Favalli EG, Ingegnoli F, De Lucia O, Cincinelli G, Cimaz R, Caporali R. COVID-19 infection and rheumatoid arthritis: Faraway, so close! Autoimmun Rev. 2020;19(5):102523.","journal-title":"Autoimmun Rev"},{"issue":"11","key":"1089_CR42","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1007\/s10067-020-05358-z","volume":"39","author":"R Roongta","year":"2020","unstructured":"Roongta R, Ghosh A. Managing rheumatoid arthritis during COVID-19. CLIN RHEUMATOL. 2020;39(11):3237\u201344.","journal-title":"CLIN RHEUMATOL"},{"issue":"7899","key":"1089_CR43","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41586-022-04427-4","volume":"603","author":"L Hosang","year":"2022","unstructured":"Hosang L, Canals RC, van der Flier FJ, et al. The lung microbiome regulates brain autoimmunity. Nature. 2022;603(7899):138\u201344.","journal-title":"Nature"},{"issue":"1","key":"1089_CR44","doi-asserted-by":"crossref","first-page":"e28431","DOI":"10.1002\/jmv.28431","volume":"95","author":"A Baranova","year":"2023","unstructured":"Baranova A, Cao H, Teng S, Su KP, Zhang F. Shared genetics and causal associations between COVID-19 and multiple sclerosis. J Med Virol. 2023;95(1):e28431.","journal-title":"J Med Virol"},{"issue":"3","key":"1089_CR45","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/jmv.26593","volume":"93","author":"MS Rostami","year":"2021","unstructured":"Rostami MS, Ghasemi-Kasman M. Impact of disease-modifying drugs on the severity of COVID-19 infection in multiple sclerosis patients. J Med Virol. 2021;93(3):1314\u20139.","journal-title":"J Med Virol"},{"issue":"4","key":"1089_CR46","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.26028","volume":"89","author":"MP Sormani","year":"2021","unstructured":"Sormani MP, De Rossi N, Schiavetti I, et al. Disease-modifying therapies and coronavirus disease 2019 severity in multiple sclerosis. Ann Neurol. 2021;89(4):780\u20139.","journal-title":"Ann Neurol"},{"issue":"1","key":"1089_CR47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/07853890.2020.1839959","volume":"53","author":"P Bansal","year":"2021","unstructured":"Bansal P, Goyal A, Cusick AT, et al. Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019. Ann Med. 2021;53(1):117\u201334.","journal-title":"Ann Med"},{"issue":"7","key":"1089_CR48","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3390\/pathogens9070546","volume":"9","author":"RS Kalra","year":"2020","unstructured":"Kalra RS, Tomar D, Meena AS, Kandimalla R. SARS-CoV-2, ACE2, and hydroxychloroquine: cardiovascular complications, therapeutics, and clinical readouts in the current settings. PATHOGENS. 2020;9(7):546.","journal-title":"PATHOGENS"},{"issue":"5","key":"1089_CR49","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1096\/fj.202000919","volume":"34","author":"EA Meyerowitz","year":"2020","unstructured":"Meyerowitz EA, Vannier A, Friesen M, et al. Rethinking the role of hydroxychloroquine in the treatment of COVID-19. FASEB J. 2020;34(5):6027\u201337.","journal-title":"FASEB J"},{"issue":"1","key":"1089_CR50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11882-020-00983-9","volume":"21","author":"A Udupa","year":"2021","unstructured":"Udupa A, Leverenz D, Balevic SJ, Sadun RE, Tarrant TK, Rogers JL. Hydroxychloroquine and COVID-19: a rheumatologist\u2019s take on the lessons learned. Curr Allergy Asthm R. 2021;21(1):5.","journal-title":"Curr Allergy Asthm R"},{"key":"1089_CR51","doi-asserted-by":"crossref","first-page":"763412","DOI":"10.3389\/fimmu.2021.763412","volume":"12","author":"A Furlan","year":"2021","unstructured":"Furlan A, Forner G, Cipriani L, et al. COVID-19 in B cell-depleted patients after rituximab: a diagnostic and therapeutic challenge. Front Immunol. 2021;12:763412.","journal-title":"Front Immunol"},{"issue":"1","key":"1089_CR52","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00415-020-10362-z","volume":"269","author":"CG Chisari","year":"2022","unstructured":"Chisari CG, Sgarlata E, Arena S, Toscano S, Luca M, Patti F. Rituximab for the treatment of multiple sclerosis: a review. J NEUROL. 2022;269(1):159\u201383.","journal-title":"J NEUROL"},{"issue":"4","key":"1089_CR53","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/imm.13443","volume":"165","author":"Y Chen","year":"2022","unstructured":"Chen Y, Xu Z, Wang P, et al. New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology. 2022;165(4):386\u2013401.","journal-title":"Immunology"},{"issue":"9","key":"1089_CR54","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/jnnp-2022-329123","volume":"93","author":"M Etemadifar","year":"2022","unstructured":"Etemadifar M, Nouri H, Pitzalis M, et al. Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis. J Neurol Neurosur Ps. 2022;93(9):986\u201394.","journal-title":"J Neurol Neurosur Ps"},{"issue":"2","key":"1089_CR55","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cei.13495","volume":"202","author":"D Baker","year":"2020","unstructured":"Baker D, Roberts C, Pryce G, et al. COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases. Clin Exp Immunol. 2020;202(2):149\u201361.","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"1089_CR56","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/mus.27681","volume":"66","author":"A Gil-Vila","year":"2022","unstructured":"Gil-Vila A, Ravichandran N, Selva-O\u2019Callaghan A, et al. COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies. Muscle Nerve. 2022;66(4):426\u201337.","journal-title":"Muscle Nerve"},{"key":"1089_CR57","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac624","author":"R Naveen","year":"2022","unstructured":"Naveen R, Parodis I, Joshi M, et al. COVID-19 vaccination in autoimmune diseases (COVAD) Study: vaccine safety and tolerance in rheumatoid arthritis. Rheumatology. 2022. https:\/\/doi.org\/10.1093\/rheumatology\/keac624.","journal-title":"Rheumatology"},{"issue":"3","key":"1089_CR58","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/cts.12953","volume":"14","author":"MC Sacchi","year":"2021","unstructured":"Sacchi MC, Tamiazzo S, Stobbione P, et al. SARS-CoV-2 infection as a trigger of autoimmune response. CTS-Clin Transl Sci. 2021;14(3):898\u2013907.","journal-title":"CTS-Clin Transl Sci"},{"key":"1089_CR59","doi-asserted-by":"crossref","first-page":"587517","DOI":"10.3389\/fimmu.2020.587517","volume":"11","author":"D Gagiannis","year":"2020","unstructured":"Gagiannis D, Steinestel J, Hackenbroch C, et al. Clinical, serological, and histopathological similarities between severe COVID-19 and acute exacerbation of connective tissue disease-associated interstitial lung disease (CTD-ILD). FRONT IMMUNOL. 2020;11:587517.","journal-title":"FRONT IMMUNOL"},{"issue":"2","key":"1089_CR60","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/infdis\/jiac372","volume":"227","author":"MJ Peluso","year":"2023","unstructured":"Peluso MJ, Mitchell A, Wang CY, et al. Low prevalence of interferon \u03b1 autoantibodies in people experiencing symptoms of post-coronavirus disease 2019 (COVID-19) conditions, or long COVID. J Infect Dis. 2023;227(2):246\u201350.","journal-title":"J Infect Dis"},{"issue":"7","key":"1089_CR61","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1515\/cclm-2022-0239","volume":"60","author":"A Ulndreaj","year":"2022","unstructured":"Ulndreaj A, Wang M, Misaghian S, et al. Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigens. Clin Chem Lab Med. 2022;60(7):1116\u201323.","journal-title":"Clin Chem Lab Med"},{"key":"1089_CR62","doi-asserted-by":"crossref","first-page":"108694","DOI":"10.1016\/j.clim.2021.108694","volume":"226","author":"V Salle","year":"2021","unstructured":"Salle V. Coronavirus-induced autoimmunity. Clin Immunol. 2021;226:108694.","journal-title":"Clin Immunol"},{"issue":"5","key":"1089_CR63","first-page":"320","volume":"24","author":"AE Frankel","year":"2022","unstructured":"Frankel AE, Wylie D, Peters B, Marrama D, Ahn C. Bioinformatic analysis underpinning the frequent occurrence of immune thrombocytopenic purpura in COVID-19 patients. ISR Med Assoc J. 2022;24(5):320\u20136.","journal-title":"ISR Med Assoc J"},{"issue":"5","key":"1089_CR64","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s12192-020-01148-3","volume":"25","author":"GA Marino","year":"2020","unstructured":"Marino GA, L\u00e9gar\u00e9 S, Lo BG, et al. Human molecular chaperones share with SARS-CoV-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: possible role of molecular mimicry in COVID-19. Cell Stress Chaperon. 2020;25(5):737\u201341.","journal-title":"Cell Stress Chaperon"},{"issue":"11","key":"1089_CR65","doi-asserted-by":"crossref","first-page":"102941","DOI":"10.1016\/j.autrev.2021.102941","volume":"20","author":"F Elrashdy","year":"2021","unstructured":"Elrashdy F, Tambuwala MM, Hassan SS, et al. Autoimmunity roots of the thrombotic events after COVID-19 vaccination. AUTOIMMUN REV. 2021;20(11):102941.","journal-title":"AUTOIMMUN REV"},{"issue":"6","key":"1089_CR66","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3390\/biomedicines10061246","volume":"10","author":"K Guetl","year":"2022","unstructured":"Guetl K, Raggam RB, Gary T. Thrombotic complications after COVID-19 vaccination: diagnosis and treatment options. Biomedicines. 2022;10(6):1246.","journal-title":"Biomedicines"},{"issue":"3","key":"1089_CR67","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3390\/biology11030372","volume":"11","author":"A Roberti","year":"2022","unstructured":"Roberti A, Chaffey LE, Greaves DR. NF-\u03baB signaling and inflammation-drug repurposing to treat inflammatory disorders? Biology-Basel. 2022;11(3):372.","journal-title":"Biology-Basel"},{"issue":"12","key":"1089_CR68","doi-asserted-by":"crossref","first-page":"e14259","DOI":"10.1111\/jfbc.14259","volume":"46","author":"V Chattree","year":"2022","unstructured":"Chattree V, Singh K, Singh K, Goel A, Maity A, Lone A. A comprehensive review on modulation of SIRT1 signaling pathways in the immune system of COVID-19 patients by phytotherapeutic melatonin and epigallocatechin-3-gallate. J Food Biochem. 2022;46(12):e14259.","journal-title":"J Food Biochem"},{"issue":"2","key":"1089_CR69","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","volume":"4","author":"EA Franzosa","year":"2019","unstructured":"Franzosa EA, Sirota-Madi A, Avila-Pacheco J, et al. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol. 2019;4(2):293\u2013305.","journal-title":"Nat Microbiol"},{"issue":"33","key":"1089_CR70","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.3748\/wjg.v27.i33.5520","volume":"27","author":"C Vigan\u00f2","year":"2021","unstructured":"Vigan\u00f2 C, Mulinacci G, Palermo A, et al. Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future. World J Gastroentero. 2021;27(33):5520\u201335.","journal-title":"World J Gastroentero"},{"issue":"12","key":"1089_CR71","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1002\/jmv.28067","volume":"94","author":"SS Tao","year":"2022","unstructured":"Tao SS, Wang XY, Yang XK, et al. COVID-19 and inflammatory bowel disease crosstalk: from emerging association to clinical proposal. J Med Virol. 2022;94(12):5640\u201352.","journal-title":"J Med Virol"},{"key":"1089_CR72","doi-asserted-by":"crossref","first-page":"102592","DOI":"10.1016\/j.jaut.2020.102592","volume":"117","author":"L Novelli","year":"2021","unstructured":"Novelli L, Motta F, De Santis M, Ansari AA, Gershwin ME, Selmi C. The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19-a systematic review of the literature. J Autoimmun. 2021;117:102592.","journal-title":"J Autoimmun"},{"issue":"1","key":"1089_CR73","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/jmv.26279","volume":"93","author":"V Gomez-Mayordomo","year":"2021","unstructured":"Gomez-Mayordomo V, Montero-Escribano P, Mat\u00edas-Guiu JA, Gonz\u00e1lez-Garc\u00eda N, Porta-Etessam J, Mat\u00edas-Guiu J. Clinical exacerbation of SARS-CoV2 infection after fingolimod withdrawal. J Med Virol. 2021;93(1):546\u20139.","journal-title":"J Med Virol"},{"issue":"7","key":"1089_CR74","doi-asserted-by":"crossref","first-page":"e20210554","DOI":"10.1084\/jem.20210554","volume":"218","author":"P Bastard","year":"2021","unstructured":"Bastard P, Orlova E, Sozaeva L, et al. Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1. J Exp Med. 2021;218(7):e20210554.","journal-title":"J Exp Med"},{"issue":"10","key":"1089_CR75","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3390\/medicina56100521","volume":"56","author":"PI Huang","year":"2020","unstructured":"Huang PI, Lin TC, Liu FC, et al. Positive Anti-SSA\/Ro antibody in a woman with SARS-CoV-2 infection using immunophenotyping: a case report. Medicina-Lithuania. 2020;56(10):521.","journal-title":"Medicina-Lithuania"},{"issue":"1","key":"1089_CR76","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s40744-021-00395-9","volume":"9","author":"AA Drosos","year":"2022","unstructured":"Drosos AA, Pelechas E, Voulgari PV. Seronegative erosive arthritis following SARS-CoV-2 infection. Rheumatol Ther. 2022;9(1):295\u2013301.","journal-title":"Rheumatol Ther"},{"issue":"2","key":"1089_CR77","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/vaccines10020333","volume":"10","author":"C Thurm","year":"2022","unstructured":"Thurm C, Reinhold A, Borucki K, et al. Homologous and heterologous anti-COVID-19 vaccination does not induce new-onset formation of autoantibodies typically accompanying lupus erythematodes, rheumatoid arthritis, celiac disease and antiphospholipid syndrome. Vaccines-Basel. 2022;10(2):333.","journal-title":"Vaccines-Basel"},{"key":"1089_CR78","doi-asserted-by":"crossref","first-page":"838011","DOI":"10.3389\/fimmu.2022.838011","volume":"13","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Chen X, Liu X. NETosis and neutrophil extracellular traps in COVID-19: immunothrombosis and beyond. Front Immunol. 2022;13:838011.","journal-title":"Front Immunol"},{"issue":"3","key":"1089_CR79","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.3390\/ijms24033001","volume":"24","author":"R Root-Bernstein","year":"2023","unstructured":"Root-Bernstein R. From co-infections to autoimmune disease via hyperactivated innate immunity: COVID-19 autoimmune coagulopathies, autoimmune myocarditis and multisystem inflammatory syndrome in children. Int J Mol Sci. 2023;24(3):3001.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1089_CR80","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/path.5642","volume":"254","author":"LE van Eijk","year":"2021","unstructured":"van Eijk LE, Binkhorst M, Bourgonje AR, et al. COVID-19: immunopathology, pathophysiological mechanisms, and treatment options. J Pathol. 2021;254(4):307\u201331.","journal-title":"J Pathol"},{"key":"1089_CR81","doi-asserted-by":"crossref","first-page":"155873","DOI":"10.1016\/j.cyto.2022.155873","volume":"154","author":"L Mobasheri","year":"2022","unstructured":"Mobasheri L, Nasirpour MH, Masoumi E, Azarnaminy AF, Jafari M, Esmaeili SA. SARS-CoV-2 triggering autoimmune diseases. Cytokine. 2022;154:155873.","journal-title":"Cytokine"},{"key":"1089_CR82","doi-asserted-by":"crossref","first-page":"1069444","DOI":"10.3389\/fimmu.2022.1069444","volume":"13","author":"HM Lazarus","year":"2022","unstructured":"Lazarus HM, Pitts K, Wang T, et al. Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders. Front Immunol. 2022;13:1069444.","journal-title":"Front Immunol"},{"issue":"6","key":"1089_CR83","doi-asserted-by":"crossref","first-page":"e2334","DOI":"10.1002\/rmv.2334","volume":"32","author":"MM Mahboubi","year":"2022","unstructured":"Mahboubi MM, Karvandi MS, Maafi P, Doroudian M. Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches. REV MED VIROL. 2022;32(6):e2334.","journal-title":"REV MED VIROL"},{"issue":"24","key":"1089_CR84","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.2169\/internalmedicine.0371-22","volume":"61","author":"S Kato","year":"2022","unstructured":"Kato S, Yoshikura N, Kimura A, Shimohata T. Possible autoimmune encephalitis associated with the severe acute respiratory syndrome coronavirus 2 omicron variant successfully treated with steroids. Internal Med. 2022;61(24):3739\u201341.","journal-title":"Internal Med"},{"key":"1089_CR85","doi-asserted-by":"crossref","first-page":"1149612","DOI":"10.3389\/fneur.2023.1149612","volume":"14","author":"K Poli","year":"2023","unstructured":"Poli K, Kowarik M, Hamprecht K, et al. Recurrent acute disseminated encephalomyelitis (ADEM) after COVID-19-vaccination and after subsequent COVID-19-infection: a case report (part II). Front Neurol. 2023;14:1149612.","journal-title":"Front Neurol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01089-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01089-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01089-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T20:24:24Z","timestamp":1698783864000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01089-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":85,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["1089"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01089-y","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,3]]},"assertion":[{"value":"6 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests. The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The data are all from the public database Web of Science, which does not involve ethical issues.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}